SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31
SciSparc Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 29, 2026
$1.40−0.30 (-17.65%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
Share price
−$32.98 (−95.93%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
SciSparc Ltd. saw revenue fall 54.6% to $1.31M over fiscal 2024.
Revenue
$1.31M
-54.6% vs. a year earlier
Operating income
-$7.32M
FY2024
EPS, diluted
$26.88
-91.1% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Jun 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- 0.1
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.31M
- Net income
- -$6.28M
- EPS, diluted
- $26.88
Eleven years at a glance
Fiscal years 2014 to 2024, USD
Revenue
$1.31M-54.6% YoY
Gross profit
$506.00K-77.0% YoY
Operating income
-$7.32M
Net income
-$6.28M
EPS, diluted
$26.88-91.1% YoY
Free cash flow
–
Reported period